Re-watch the Australian Showcase on demand

 This showcase highlights how Australia’s clinical trials are a cornerstone for innovation, actively supports innovative local companies with their R&D and offers an attractive environment for companies from around the world to develop their intellectual property in Australia.

If you have any questions about clinical trials, AusBiotech, or working in Australia, or if you would like to connect with a webcast speaker, we would be delighted to facilitate an introduction - contact us here.

Agenda

• The strength of the Australian bio-economy, Lorraine Chiroiu | CEO | AusBiotech

• Opportunities in Australia’s healthcare sector, Benson Saulo | Consul-General to the US, based in Houston | Austrade (begins 6.17min)

• How the New South Wales Government is supporting clinical trials and advanced therapeutics, Anne O’Neill | Director Enterprise and International Partnerships | NSW Office for Health and Medical Research | Ministry of Health (begins 13.21)

• How the Victorian Government is supporting clinical trials and medical innovations, Caroline Edwards PSM | Commissioner for Victoria to the Americas | Victorian Government (begins 25.27)

• How the Queensland Government is supporting clinical trials and medical innovations, Karen Thompson | Senior Director, Health Innovation, Investment and Research Office | Queensland Health (begins 38.05)

• Australia as a destination for Clinical Trials – capabilities and infrastructure, Dr Megan Robertson | St Vincent’s Health (begins 58.10)

• Conducting clinical trials in Australia – ethics, approvals and lead times, Kylie Sproston | Bellberry (begins 1.08.00)

• Why Australia should be a priority market for medical innovation, Luis Jimenez | PharmaLex (begins 1.17.04)

• Fast track your Phase 1 clinical trial – understanding the regulatory differences between Australia and the USA, Dr Graham Wood | Nucleus Network (begins 1.27.00)

• Case study for international companies conducting clinical trials in Australia (lab services), Catherine Osborne | Crux Biolabs (begins 1.36.41)

• Strength of Australia’s IP framework for clinical trials, Dr Michael Christie | Spruson & Ferguson (begins 1.41.30)

• Australia’s advantages of utilising local labs to expedite data review and your Phase 1 clinical trial, Angela Lutterick | 360 biolabs (begins 1.55.06)

• Australia’s early phase sites: where the rubber hits the road, Jane Kelly | CMAX (begins 2.02.24)

• What you need to run your clinical trials in Australia, Dr Tina Soulis | Alithia Life Sciences (begins 2.12.45).